Select Medical Holdings (SEM) Cost of Revenue (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Cost of Revenue data on file, last reported at $1.2 billion in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $1.2 billion, up 6.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 6.33% YoY), and the FY2025 annual result was $4.8 billion, up 5.93% from the prior year.
• Cost of Revenue was little changed at $1.2 billion in Q1 2026 per SEM's latest filing, from $1.3 billion in the prior quarter.
• Over five years, Cost of Revenue peaked at $1.4 billion in Q1 2022 and troughed at $16.3 million in Q4 2022.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2025 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue slumped 98.84% in 2022, then surged 6485.7% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $16.3 million in 2022, then surged by 6485.7% to $1.1 billion in 2023, then gained by 9.41% to $1.2 billion in 2024, then climbed by 6.44% to $1.3 billion in 2025, then dropped by 0.38% to $1.2 billion in 2026.
• Business Quant data shows SEM's Cost of Revenue at $1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.